<VariationArchive RecordType="classified" VariationID="560550" VariationName="NM_000151.4(G6PC1):c.388_400del (p.Met130fs)" VariationType="Deletion" Accession="VCV000560550" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2018-09-13" MostRecentSubmission="2018-09-13">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="551628" VariationID="560550">
      <GeneList>
        <Gene Symbol="G6PC1" FullName="glucose-6-phosphatase catalytic subunit 1" GeneID="2538" HGNC_ID="HGNC:4056" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="42900799" stop="42914438" display_start="42900799" display_stop="42914438" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="41052813" stop="41066449" display_start="41052813" display_stop="41066449" Strand="+" />
          </Location>
          <OMIM>613742</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000151.4(G6PC1):c.388_400del (p.Met130fs)</Name>
      <CanonicalSPDI>NC_000017.11:42907569:ATGGTCACATCTA:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q21.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="42907570" stop="42907582" display_start="42907570" display_stop="42907582" variantLength="13" positionVCF="42907569" referenceAlleleVCF="GATGGTCACATCTA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="41059587" stop="41059599" display_start="41059587" display_stop="41059599" variantLength="13" positionVCF="41059586" referenceAlleleVCF="GATGGTCACATCTA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>M130fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011808.1" sequenceAccession="NG_011808" sequenceVersion="1" change="g.11773_11785del">
            <Expression>NG_011808.1:g.11773_11785del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000151.4" sequenceAccession="NM_000151" sequenceVersion="4" change="c.388_400del" MANESelect="true">
            <Expression>NM_000151.4:c.388_400del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000142.2" sequenceAccession="NP_000142" sequenceVersion="2" change="p.Met130fs">
            <Expression>NP_000142.2:p.Met130fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001270397.2" sequenceAccession="NM_001270397" sequenceVersion="2" change="c.341-30_341-18del">
            <Expression>NM_001270397.2:c.341-30_341-18del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.41059587_41059599del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.41059587_41059599del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.42907570_42907582del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.42907570_42907582del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_147" sequenceAccession="LRG_147" change="g.11773_11785del">
            <Expression>LRG_147:g.11773_11785del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1567705064" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000151.4(G6PC1):c.388_400del (p.Met130fs) AND Glycogen storage disease due to glucose-6-phosphatase deficiency type IA" Accession="RCV000678678" Version="1">
        <ClassifiedConditionList TraitSetID="3246">
          <ClassifiedCondition DB="MedGen" ID="C2919796">Glycogen storage disease due to glucose-6-phosphatase deficiency type IA</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2018-09-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-09-05" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-09-13" MostRecentSubmission="2018-09-13">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="3246" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10924" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GSD Ia</ElementValue>
                <XRef Type="MIM" ID="232200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease type 1A</ElementValue>
                <XRef ID="Glycogen+Storage+Disease+Type+1A/3120" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Von Gierke disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogenosis type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hepatorenal form of glycogen storage disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glucose-6-phosphatase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hepatorenal glycogenosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glucose-6-phosphatase deficiency glycogen storage disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease due to glucose-6-phosphatase deficiency type IA</ElementValue>
                <XRef ID="MONDO:0009287" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">GSD1</ElementValue>
                <XRef Type="MIM" ID="232200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">GSD1A</ElementValue>
                <XRef Type="MIM" ID="232200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Glycogen storage disease type I (GSDI) is characterized by accumulation of glycogen and fat in the liver and kidneys resulting in hepatomegaly and nephromegaly. Severely affected infants present in the neonatal period with severe hypoglycemia due to fasting intolerance. More commonly, untreated infants present at age three to four months with hepatomegaly, severe hypoglycemia with or without seizures, lactic acidosis, hyperuricemia, and hypertriglyceridemia. Affected children typically have doll-like faces with full cheeks, relatively thin extremities, short stature, and a protuberant abdomen. Xanthoma and diarrhea may be present. Impaired platelet function and development of reduced or dysfunctional von Willebrand factor can lead to a bleeding tendency with frequent epistaxis and menorrhagia in females. Individuals with untreated GSDIb are more likely to develop impaired neutrophil and monocyte function as well as chronic neutropenia resulting in recurrent bacterial infections, gingivitis, periodontitis, and genital and intestinal ulcers. Long-term complications of untreated GSDI include short stature, osteoporosis, delayed puberty, renal disease (including proximal and distal renal tubular acidosis, renal stones, and renal failure), gout, systemic hypertension, pulmonary hypertension, hepatic adenomas with potential for malignancy, pancreatitis, and polycystic ovaries. Seizures and cognitive impairment may occur in individuals with prolonged periods of hypoglycemia. Normal growth and puberty are expected in treated children. Most affected individuals live into adulthood.</Attribute>
                <XRef ID="NBK1312" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7864" />
                <XRef ID="7864" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301489</ID>
                <ID Source="BookShelf">NBK1312</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG, 2014">
                <ID Source="PubMed">25356975</ID>
              </Citation>
              <XRef ID="364" DB="Orphanet" />
              <XRef ID="79258" DB="Orphanet" />
              <XRef ID="C2919796" DB="MedGen" />
              <XRef ID="MONDO:0009287" DB="MONDO" />
              <XRef Type="MIM" ID="232200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1569675" SubmissionDate="2018-09-11" DateLastUpdated="2018-09-13" DateCreated="2018-09-13">
        <ClinVarSubmissionID localKey="SUB4490057" submittedAssembly="GRCh37" title="SUB4490057" />
        <ClinVarAccession Accession="SCV000804318" DateUpdated="2018-09-13" DateCreated="2018-09-13" Type="SCV" Version="1" SubmitterName="Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics" OrgID="505565" OrganizationCategory="other" OrgAbbreviation="FRIGE - IHG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-09-05">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The observed variant c.388_400delATGGTCACATCTA has not been reported in 1000 Genomes and ExAC databases. The in silico prediction of the given variant is damaging by MutationTaster2.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Indian Hindu</Ethnicity>
              <GeographicOrigin>India</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <NamePlatform>Illumina sequencing platform</NamePlatform>
              <TypePlatform>Next-generation sequencing</TypePlatform>
              <Description>DNA was used to perform targeted gene sequencing using a custom capture kit. Libraries were sequenced to mean &gt;80-100X coverage in Illumina sequencing platform. Sequence obtained were aligned to human reference genome using BWA program and analyzed using Picard and GATK-Lite toolkit to identify variants in the targeted genes relevant to clinical indication.</Description>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <TraitSet DateLastEvaluated="2018-09-05" Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0002240" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0003270" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0500011" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001744" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0003155" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0030948" />
              </Trait>
              <Comment>The patient had elevated levels of triglycerides, uric acid, serum glutamic oxaloacetic transaminase and serum glutamic pyruvic transaminase.</Comment>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="G6PC">
              <Name>glucose-6-phosphatase catalytic subunit</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000151.3:exon 3</GeneLocation>
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">D-4226</Name>
            <Name>p.Met130LeufsTer9</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000151.3:c.388_400delATGGTCACATCTA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="232200" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4490057</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1569675" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003270" MappingRef="HP">
        <MedGen CUI="C0000731" Name="Abdominal distention" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1569675" TraitType="Finding" MappingType="XRef" MappingValue="HP:0500011" MappingRef="HP">
        <MedGen CUI="C0332601" Name="Moon facies" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1569675" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002240" MappingRef="HP">
        <MedGen CUI="C0019209" Name="Hepatomegaly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1569675" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001744" MappingRef="HP">
        <MedGen CUI="C0038002" Name="Splenomegaly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1569675" TraitType="Finding" MappingType="XRef" MappingValue="HP:0030948" MappingRef="HP">
        <MedGen CUI="C4476869" Name="Elevated gamma-glutamyltransferase level" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1569675" TraitType="Disease" MappingType="XRef" MappingValue="232200" MappingRef="OMIM">
        <MedGen CUI="C2919796" Name="Glycogen storage disease due to glucose-6-phosphatase deficiency type IA" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1569675" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003155" MappingRef="HP">
        <MedGen CUI="C1314665" Name="Elevated circulating alkaline phosphatase concentration" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1569675" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001250" MappingRef="HP">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

